This Article Full Text Full Text (PDF) All Versions of this Article: 113/20/2391    most recent CIRCULATIONAHA.106.622076v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Khairy, P. Search for Related Content PubMed PubMed Citation Articles by Khairy, P. Pubmed/NCBI databases Medline Plus Health Information Congenital Heart Defects Related Collections Pacemaker Pediatric and congenital heart disease, including cardiovascular surgery

(Circulation. 2006;113:2391-2397.)
© 2006 American Heart Association, Inc.

Congenital Heart Disease

Transvenous Pacing Leads and Systemic Thromboemboli in Patients With Intracardiac Shunts

A Multicenter Study

Paul Khairy, MD, PhD; Michael J. Landzberg, MD; Michael A. Gatzoulis, MD, PhD; Lise-Andrée Mercier, MD; Susan M. Fernandes, MPH, PA-C; Jean-Marc Côté, MD; Jean-Pierre Lavoie, MD; Anne Fournier, MD; Peter G. Guerra, MD; Alexandra Frogoudaki, MD; Edward P. Walsh, MD; Annie Dore, MD, for the Epicardial Versus ENdocardial pacing and Thromboembolic events (EVENT) Investigators

From the Adult Congenital Heart and Electrophysiology Services (P.K., L.-A.M., P.G.G., J.-P.L., A.D.), Montreal Heart Institute, Montreal, Canada; Boston Adult Congenital Heart and Electrophysiology Services (P.K., M.J.L., S.M.F., E.P.W.), Children’s Hospital, Boston, Mass; the Adult Congenital Heart Unit (M.A.G., A.F.), Royal Brompton Hospital, London, England; the Institut Universitaire de Cardiologie et de Pneumologie (J.-M.C.), Quebec, Canada; and the Cardiology Service (A.F.), Sainte-Justine Hospital, Montreal, Canada.

Reprint requests to Dr Paul Khairy, Electrophysiology and Adult Congenital Heart Disease, Montreal Heart Institute, 5000 Belanger St E, Montreal, QC, Canada, H1T 1C8. E-mail paul.khairy{at}umontreal.ca

Received November 16, 2005; de novo received February 19, 2006; accepted March 15, 2006.

Background— The risk of systemic thromboemboli associated with transvenous leads in the presence of an intracardiac shunt is currently unknown.

Methods and Results— To define this risk, we conducted a multicenter, retrospective cohort study of 202 patients with intracardiac shunts: Sixty-four had transvenous leads (group 1), 56 had epicardial leads (group 2), and 82 had right-to-left shunts but no pacemaker or implantable cardioverter defibrillator leads (group 3). Patient-years were accrued until the occurrence of systemic thromboemboli or study termination. Censoring occurred in the event of complete shunt closure, death, or loss to follow-up. Mean ages for groups 1, 2, and 3 were 33.9±18.0, 22.2±12.6, and 22.9±15.0 years, respectively. Respective oxygen saturations were 91.2±9.1%, 88.1±8.1%, and 79.7±6.7%. During respective median follow-ups of 7.3, 9.3, and 17.0 years, 24 patients had at least 1 systemic thromboembolus: 10 (15.6%), 5 (8.9%), and 9 (11.0%) in groups 1, 2, and 3, respectively. Univariate risk factors were older age (hazard ratio [HR], 1.05; P=0.0001), ongoing phlebotomy (HR, 3.1; P=0.0415), and an transvenous lead (HR, 2.4; P=0.0421). In multivariate, stepwise regression analyses, transvenous leads remained an independent predictor of systemic thromboemboli (HR, 2.6; P=0.0265). In patients with transvenous leads, independent risk factors were older age (HR, 1.05; P=0.0080), atrial fibrillation or flutter (HR, 6.7; P=0.0214), and ongoing phlebotomy (HR, 14.4; P=0.0349). Having had aspirin or warfarin prescribed was not protective. Epicardial leads were, however, associated with higher atrial (P=0.0407) and ventricular (P=0.0270) thresholds and shorter generator longevity (HR, 1.9; P=0.0176).

Conclusions— Transvenous leads incur a >2-fold increased risk of systemic thromboemboli in patients with intracardiac shunts.

---

 

CLINICAL PERSPECTIVE

This article has been cited by other articles:

				A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices) Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons J. Am. Coll. Cardiol., May 27, 2008; 51(21): e1 - e62. [Full Text] [PDF]

				A. E. Epstein, J. P. DiMarco, K. A. Ellenbogen, N.A. M. Estes III, R. A. Freedman, L. S. Gettes, A. M. Gillinov, G. Gregoratos, S. C. Hammill, D. L. Hayes, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices): Developed in Collaboration With the American Association for Thoracic Surgery and Society of Thoracic Surgeons Circulation, May 27, 2008; 117(21): e350 - e408. [Full Text] [PDF]

				M. Tomaske, B. Gerritse, L. Kretzers, R. Pretre, A. Dodge-Khatami, M. Rahn, and U. Bauersfeld A 12-year experience of bipolar steroid-eluting epicardial pacing leads in children. Ann. Thorac. Surg., May 1, 2008; 85(5): 1704 - 1711. [Abstract] [Full Text] [PDF]

				E. P. Walsh Interventional Electrophysiology in Patients With Congenital Heart Disease Circulation, June 26, 2007; 115(25): 3224 - 3234. [Full Text] [PDF]

				P. Khairy, N. Poirier, and L.-A. Mercier Univentricular Heart Circulation, February 13, 2007; 115(6): 800 - 812. [Abstract] [Full Text] [PDF]